Blocking collagen signaling improves the delivery of macromolecular drugs in pancreatic cancer
Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in oncology.
Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in oncology.